Pentagon issues new guidance for testosterone testing after rescinding previous one
The Pentagon issued new guidance late Thursday instructing mandatory testosterone deficiency screening for male active-duty and reserve service members over the age of 30 after temporarily rescinding previous guidance earlier this month. The department said the updated guidance will address male testosterone deficiency and establish uniform screening and treatment pathways across the Defense…
The Pentagon has reinstated a mandatory testing program for testosterone deficiency among US service members aged 30 and older, according to a spokesperson on Thursday. This program, previously paused, brings back a policy many medical experts have deemed unnecessary and potentially harmful. US Defence Secretary Pete Hegseth first announced the screening mandate in July, promoting the use of testosterone to enhance military readiness.
Initially, women were also to be screened through a questionnaire, potentially leading to treatment for hormonal imbalance-related conditions. However, the Pentagon temporarily suspended the published medical guidance for the testosterone screening in early September to allow for updates. The recent decision to lift the pause lifts the restraint, allowing testing to resume.
It remains unclear what, if any, adjustments were made to the original policy. Pentagon spokesperson Sean Parnell stated, "Effective immediately, this guidance addresses male testosterone deficiency, establishing uniform screening and treatment pathways." Medical professionals have cautioned that inappropriate prescription of testosterone could heighten service members' risk of infertility or cause other health complications.
Written by urgent.news from Dawn's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
